Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials
Tickers CLNN
Tags Market News Phase 2 Trial Penny Stocks
From Benzinga
BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market
Tickers BBIO
Tags Movers News Briefs
From Benzinga
Scholar Rock To Highlight Apitegromab Data From Ambulatory Cohort In Muscular Dystrophy
Tickers SRRK
Tags General Health Care Spinal Muscular Atrophy
From Benzinga
Why Sanofi Shares Are Trading Lower Today
Tickers SNY
Tags breast cancer Movers why it's moving
From Benzinga
Moderna Starts Dosing In Mid-Stage Omicron-Specific Bivalent Booster Candidate
Tickers MRNA
Tags Health Care General COVID/19 Coronavirus
From Benzinga
FDA Gives Green Signal To Inventiva's Mid-Stage Lanifibranor Study In NASH Patients
Tickers IVA
Tags General Health Care Small Cap
From Benzinga
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
Tickers ALKS
Tags General Movers News
From Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
Tickers AMGN
Tags Pancreatic Cancer General Health Care
From Benzinga
ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting
Tickers ENDP IBRX MRK
Tags Health Care IBRX Small Cap
From Benzinga
BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer
Tickers BTAI MRK
Tags BTAI metastatic castration/resistant prostate cancer Briefs
From Benzinga
Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
Tickers OPT
Tags Market News OPT Phase 2 Trial
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
Tickers RGNX
Tags Health Care Phase 1 Trial gene therapy
From Benzinga
4D Molecular Shares Updated Data From Fabry Disease Trial
Tickers FDMT
Tags Market News Phase 2 Trial Trading Ideas
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Tickers AVRO
Tags News General AVRO
From Benzinga
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
Tickers NLSP
Tags Briefs News Movers
From Benzinga
Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward
Tickers PFE VALN
Tags General Briefs News
From Benzinga
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
Tickers ALT
Tags ALT Health Care General
From Benzinga
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
Tickers JNJ KLDO
Tags Health Care KLDO Biotech
From Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
Tickers TSHA
Tags Benzinga Trading Ideas Phase 2 Trial
From Benzinga
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
Tickers LBPS
Tags General asthma Briefs
From Benzinga
Why Are Tyme Technologies Shares Staring At 52-Week Low
Tickers TYME
Tags Health Care Biotech Trading Ideas
From Benzinga
Two Organizations To Support Wave Life Sciences' FTD, ALS Program
Tickers WVE
Tags General Briefs News
From Benzinga
Imara To Start Testing Tovinontrine In Heart Failure Patients
Tickers IMRA
Tags Market News Phase 2 Trial Penny Stocks
From Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Tickers FBIO MBIO
Tags gene therapy Biotech Health Care
From Benzinga
89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health
Tickers ETNB
Tags Non Alcoholic steatohepatitis Benzinga ETNB
From Benzinga
Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA
Tickers TNGX
Tags General Briefs News
From Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
Tickers SABS
Tags Benzinga Market News Phase 2 Trial
From Benzinga
MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers
Tickers MDWD
Tags General Health Care News
From Benzinga
Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients
Tickers MRTX
Tags Benzinga Market News Phase 2 Trial
From Benzinga
Provention Bio Starts Mid-Stage Lupus Trial; Data Expected In 2024
Tickers PRVB
Tags Health Care Biotech Systemic Lupus Erythematosus
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.